MedPath

Viral load of SARS-CoV-2 in gas from pneumoperitoneum in minimally invasive surgery compared to open surgery

Recruiting
Conditions
07.1 COVD-19
Registration Number
DRKS00025497
Lead Sponsor
Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Universitätsklinikum Heidelberg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Patients with confirmed SARS-CoV-2 infection with an urgent need for either minimally invasive or open visceral or general surgery will be included in the study. Patients agree to participate by signing and dating the informed consent form before the surgical procedure. It is planned to take samples from patients with SARS-CoV-2 infection who, due to the urgency of immediate medical or surgical treatment, or at the time of the intervention or sampling, are sedated, ventilated, or unstable and therefore unable to give consent at the time. The taking of the samples and participation in the study is determined by detailed information of the patient's representative. The informed consent is then carried out with the representative in the same way as with the patient. The patient will be informed accordingly after the ability to consent has been regained. The patients can withdraw their consent at any time. In the event of revocation, the biomaterials and data obtained will be destroyed and deleted accordingly. Only those patients without SARS-CoV-2 infection who are capable of giving consent will be included in the study. The patient's age of majority is a prerequisite for participating in the study.

Exclusion Criteria

Underage

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Detection and comparison of the SARS-CoV-2 viral load in gas from pneumoperitoneum obtained at the end of the minimally invasive surgical interventions and in the samples from the smoke evacuation system during the open surgical interventions.
Secondary Outcome Measures
NameTimeMethod
Detection and comparison of the SARS-CoV-2 viral load between the patients undergoing minimally invasive surgical procedures and the patients undergoing open abdominal surgeries:<br>• in the room air at the end of each operation<br>• taken in the intra-abdominal smear during each operation<br>• in blood samples from all patients<br>• in stool samples in all patients<br>• in urine samples in all patients<br>• in the throat swab in all patients
© Copyright 2025. All Rights Reserved by MedPath